HeartFlow, Inc’s Post

The simpleABI-Q system is changing the game in the fight against Peripheral Artery Disease (PAD). We're not stopping at diagnosis; we're preventing amputations, empowering patients, and optimizing healthcare. It's alarming that PAD leads to over 160,000 amputations each year. Early detection is crucial to avoid this outcome! Envision primary care equipped with technology that's intuitive, flexible, and dependably precise. ABI-Q is not just another medical device; it's our dedication to improved patient outcomes and a future where everyone can thrive. Remember, early detection can save limbs. See how ABI-Q is revolutionizing vascular health and preventing amputations: https://bit.ly/4a21ulf #VascularHealth #PADawareness #TechnologyForGood #EarlyDetectionSavesLimbs #PeripheralArteryDisease

Informed therapy decisions are critical for optimal #sepsis patient management to help save lives and reduce potential for long-term disability. Ideally integrated into bioMérieux’s comprehensive Sepsis Solution, VITEK® MS PRIME and VITEK® 2 are a great ID & AST combo to support earlier optimized antimicrobial treatment and effective therapy adjustment. Learn how you can leverage these solutions for improved patient management, shorter length of therapy and shorter hospital stays. See the full Sepsis Solutions 👇 https://lnkd.in/ejNhX_U5

The power and efficacy of being proactive yields amazing results.

Did you know 2 out of 3 patients received a refined management plan following physician review of the HeartFlow Plaque Analysis? https://bit.ly/4abw4tf #HeartFlow #HeartFlowPlaqueAnalysis #TruePlaqueBurden

Did you know 2 out of 3 patients received a refined management plan following physician review of the HeartFlow Plaque Analysis? https://bit.ly/4abw4tf #HeartFlow #HeartFlowPlaqueAnalysis #TruePlaqueBurden

The power of early NIV therapy: Early non-invasive therapy for Chronic Respiratory Failure (CRF) holds immense power in transforming patient outcomes. By initiating this proactive approach soon after CRF diagnosis, it minimizes the progress of respiratory failure, enhances quality of life, and reduces the need for invasive interventions. #EncoreHealthcare #Nexus #HomeRespiratoryCare #ChronicDisease #RespiratoryCare #HomeMedicalEquipment #CRF #DurableMedicalEquipment

Now physicians can confidently provide precise care for each patient. Reveal the true plaque burden with HeartFlow Plaque Analysis. Accurate. Comprehensive. Actionable. https://bit.ly/4abw4tf #HeartFlow #HeartFlowPlaqueAnalysis #TruePlaqueBurden

Read about how RCHT are focusing on quality and data and enhancing how haemorrhagic stroke patients are treated. Discover how this project is improving patient care and recovery! https://ow.ly/U0b450TnJ5X #FabNewShare

Do you feel like your quality of life is slipping away while your doctors tell you all the things your problem isn’t? It’s an all-too-familiar story. Patients are shuffled between primary care physicians, imaging centers, and specialists, each providing limited answers. It’s often up to the patient to try to put together the pieces of a medical puzzle while they’re feeling increasingly unwell, frustrated, and scared. At the Vein & Fibroid Treatment Center, we’re not just another stop on an endless medical trudge. We’re here to get to the root of your problem and to find solutions that treat the cause, rather than chasing symptoms. We won’t send you out the door for tests to identify peripheral artery disease (PAD) or other vascular or venous conditions, because we have the diagnostic equipment in-house to get the answers you need fast. To find out more about how we can help you recover the quality of life you deserve, schedule your consultation today. 📞(951) 479-3644 veinsandfibroids.com #medicalcare #delayeddiagnosis #peripheralarterydisease #PAD #symptoms #legcramps #answers #treatment

⚠️⚠️ https://lnkd.in/dQi5EJfF yesterday, We published an article discussing the efficacy and safety of levosimendan in managing advanced #heart_failure patients. We found that 1- #Levosimendan significantly enhanced heart performance and lowered death rates in patients with severe heart failure. 2- Despite its benefits for #heart function and survival, levosimendan did not reduce the frequency of hospital #readmissions or overall survival without events. 3- The use of levosimendan did not lead to an increase in adverse side effects compared with placebo.